Fig. 1From: Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinicsPrevalent use of lipid-lowering treatments (a), and of specific statin molecules (b)Back to article page